These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6713406)

  • 1. Prognostic significance of nuclear DNA content in serous ovarian tumors.
    Erhardt K; Auer G; Björkholm E; Forsslund G; Moberger B; Sifverswärd C; Wicksell G; Zetterberg A
    Cancer Res; 1984 May; 44(5):2198-202. PubMed ID: 6713406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear DNA content and nuclear atypia. Relation to survival in patients with breast adenocarcinoma and serious ovarian tumors.
    Erhardt K; Silfverswärd C; Auer G
    Anticancer Res; 1989; 9(5):1325-30. PubMed ID: 2589823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors.
    Gershenson DM; Deavers M; Diaz S; Tortolero-Luna G; Miller BE; Bast RC; Mills GB; Silva EG
    Clin Cancer Res; 1999 Dec; 5(12):4053-8. PubMed ID: 10632339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
    Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
    Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computerized image analysis and flow cytometric evaluation of ovarian borderline tumors: a study of 24 cases.
    Esposito MJ; Fuchs A
    Cytometry; 1994 Dec; 18(4):218-22. PubMed ID: 7895528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of DNA content and nuclear morphology in borderline ovarian tumors.
    Drescher CW; Flint A; Hopkins MP; Roberts JA
    Gynecol Oncol; 1993 Feb; 48(2):242-6. PubMed ID: 8428698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometry as a prognostic indicator in women with borderline epithelial ovarian tumors.
    Harlow BL; Fuhr JE; McDonald TW; Schwartz SM; Beuerlein FJ; Weiss NS
    Gynecol Oncol; 1993 Sep; 50(3):305-9. PubMed ID: 8406192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans.
    Auer G; Eriksson E; Azavedo E; Caspersson T; Wallgren A
    Cancer Res; 1984 Jan; 44(1):394-6. PubMed ID: 6690053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of the micropapillary pattern in patients with serous borderline ovarian tumors.
    Chang SJ; Ryu HS; Chang KH; Yoo SC; Yoon JH
    Acta Obstet Gynecol Scand; 2008; 87(4):476-81. PubMed ID: 18382877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
    Salvesen HB; Iversen OE; Akslen LA
    Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
    Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
    Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferating cell nuclear antigen (PCNA) and Ki-67 in epithelial ovarian tumours: correlation with DNA flow cytometric analysis.
    Karaburun S; Karaveli S; Peştereli HE; Simsek T; Sargin CF
    Adv Clin Path; 2001 Jan; 5(1-2):3-9. PubMed ID: 11753828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of prognostic factors in common ovarian tumors of varying malignancy].
    Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z
    Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image analysis of cellular DNA content in peritoneal fluid of patients with ovarian tumors of low malignant potential and invasive epithelial ovarian cancer.
    Guidozzi F; Szumel RC; Ball JH; Johnston DA; Katz RL; Kidd L
    Gynecol Oncol; 1996 May; 61(2):204-9. PubMed ID: 8626133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A quantitative study on nuclear DNA content and morphological parameters in ovarian cystadenocarcinoma].
    Liu C; Zhao Y; Sun X
    Zhonghua Fu Chan Ke Za Zhi; 1995 Dec; 30(12):738-40. PubMed ID: 8728920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
    Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.